Clinical Trial Update: Gefitinib and Etoposide in Treating Patients With Advanced Prostate Cancer That Did Not Respond to Hormone Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating gefitinib and etoposide in advanced prostate cancer resistant to hormone therapy; study terminated with results posted in 2018…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Etoposide (Etoposide)
• Gefitinib (Gefitinib)

Snippet

Sponsor: University of Nebraska | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2018-07-17